Form 4: HealthEquity Director Robert Selander Acquires 2,003 Restricted Stock Units
Insider Ownership Change
HealthEquity, Inc. Director Robert W. Selander has acquired 2,003 restricted stock units, increasing his direct beneficial ownership to 86,972 shares.
Summary
- Robert W. Selander, a Director of HealthEquity, Inc. (HQY), acquired 2,003 shares of common stock.
- The acquisition occurred on June 26, 2025.
- These shares were acquired at a price of $0, indicating they are restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of the issuer's common stock.
- The restricted stock units will vest in full on the date of HealthEquity's next annual stockholder meeting.
- Following this transaction, Mr. Selander directly beneficially owns 86,972 shares of HealthEquity common stock.
Sentiment
Score: 6
Explanation: The acquisition of restricted stock units by a director is a positive signal of alignment with shareholder interests, though it is a routine compensation event rather than a direct open-market purchase.
Positives
- Director Robert W. Selander increased his direct beneficial ownership in HealthEquity, Inc. by acquiring 2,003 restricted stock units.
- The acquisition of restricted stock units at a $0 price indicates an equity grant, aligning the director's interests with long-term shareholder value.
Negatives
- NA
Risks
- NA
Future Outlook
The acquired restricted stock units are set to vest in full on the date of HealthEquity's next annual stockholder meeting, at which point the vested shares will be delivered to the reporting person.
Industry Context
The grant of restricted stock units to a director is a common practice in the corporate sector, particularly within the healthcare technology and financial services industries, to align executive and board member incentives with long-term company performance and shareholder interests.
Related Party Transactions
- The grant of 2,003 restricted stock units to Director Robert W. Selander represents a compensation-related transaction between the company and a related party.
Stakeholder Impact
- Shareholders: The grant of restricted stock units to a director aligns management incentives with long-term shareholder value, as the value of the units is tied to the company's stock performance.
Next Steps
- Vesting of the restricted stock units on the date of the issuer's next annual stockholder meeting.
- Delivery of vested shares to the reporting person upon vesting.
Key Dates
| Date | Description |
|---|---|
| 06/26/2023 | Date the Power of Attorney for Mr. Selander was previously filed with the U.S. Securities and Exchange Commission. |
| 06/26/2025 | Date of acquisition of 2,003 restricted stock units by Director Robert W. Selander. |
| 06/30/2025 | Date the Form 4 was signed by Michael Newton, Attorney-in-Fact for Robert W. Selander. |
Keywords
HealthEquity, HQY, Form 4, Insider Trading, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership, Robert Selander
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.